
Madratol 50mg Tablet ER
Marketer
Syntonic Lifesciences
Salt Composition
Metoprolol Tartrate (50mg)
Overview Madratol 50mg Tablet ER
CardioBlock 50mg Extended-Release tablets are classified as beta-adrenergic blocking agents. This medication treats hypertension, angina pectoris (chest pain linked to the heart), and cardiac arrhythmias. It also helps prevent recurrent heart attacks, strokes, and migraine episodes. CardioBlock 50mg ER is additionally employed to manage hyperthyroidism symptoms. Prescribing may involve solo administration or combination therapy with other drugs. Dosage and frequency are individualized based on the treated condition and its severity. It can be taken with or without food, but consistent daily timing is crucial for optimal effectiveness. Full therapeutic benefit might take several weeks, and lifelong use may be necessary. Continued use is vital even with symptom improvement, as hypertension is often asymptomatic, and discontinuation can exacerbate the condition. Common, generally mild and transient, adverse effects include hypotension, bradycardia, cephalalgia, dizziness, and nausea. Some patients may experience dyspnea or low blood pressure. To minimize adverse reactions, initial dosing is typically low, with gradual increases. Report persistent or bothersome side effects to your physician. Prior to initiation, disclose any liver dysfunction. CardioBlock 50mg ER is unsuitable for individuals with bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Pregnant or lactating women should seek medical advice before use. Always consult your doctor to assess suitability and monitor blood pressure regularly to gauge treatment efficacy. Alcohol consumption should be avoided due to the potential for increased side effect occurrence.
Primary Ingredients of Madratol 50mg Tablet ER
No text provided. Please provide the text you want me to rephrase.
Uses of Madratol 50mg Tablet ER
Managing angina pectoris (chest pain of cardiac origin) | Addressing cardiac arrhythmias | Reducing the risk of myocardial infarction | Hypertension (high blood pressure) management | Migraine prophylaxis
Major Benefits of Madratol 50mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 50mg Madratol Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.
Common Side effects of Madratol 50mg Tablet ER:
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Slow heart rate
- Headache
- Dizziness
- Tiredness
- Stomach pain
- Nausea
- Breathlessness
How to use Madratol 50mg Tablet ER:
Consume Madratol 50mg Extended-Release Tablets precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication should be taken with food.
How Madratol 50mg Tablet ER works:
Cardio-50 Extended Release tablets contain a rapidly-acting beta-adrenergic blocking agent targeted at the cardiac muscle. Its mechanism involves reducing heart rate and enhancing the heart's pumping efficiency throughout the circulatory system.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Madratol 50mg Extended-Release Tablets and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Madratol 50mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Madratol 50mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Madratol 50mg Extended-Release Tablets on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Extended-release Madratol 50mg tablets are considered safe for patients with impaired renal function. No dosage modification is necessary for Madratol 50mg extended-release tablets in this population.
LiverSAFE IF PRESCRIBED
Extended-release Madratol 50mg tablets can be administered to patients with hepatic impairment without requiring dosage modification.
What if you forget to take Madratol 50mg Tablet ER :
Should you forget a Madratol 50mg Extended-Release Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Madratol 50mg Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Alcohols and Phenols |
| Developing Habits | No. |
| Type of Therapy | Heart |
